| Cutaneous Melanoma altered in cohorts of …ALTERED_INderived200 of 510show all (up to 200) |
|---|
| ← altered in cohorts of | TERT 575 / 696 cases (83 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 388 / 470 cases (83 %) · ssm · TCGA-SKCM · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC16 377 / 470 cases (80 %) · ssm · TCGA-SKCM · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | gdc | graph → |
| ← altered in cohorts of | ANK3 375 / 470 cases (80 %) · ssm · TCGA-SKCM · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2B 356 / 470 cases (76 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMBT1 352 / 470 cases (75 %) · ssm · TCGA-SKCM · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | FREM1 352 / 470 cases (75 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTAP 351 / 470 cases (75 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAH5 350 / 470 cases (74 %) · ssm · TCGA-SKCM · largest of 10 cohorts | — | — | Cutaneous Melanoma | 10 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRTA1 346 / 470 cases (74 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCLO 342 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | gdc | graph → |
| ← altered in cohorts of | TAF1L 342 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | ADAMTSL1 341 / 470 cases (73 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA16 341 / 470 cases (73 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNE 341 / 470 cases (73 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYNE1 341 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA7 340 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA14 339 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA4 339 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MGAM 339 / 470 cases (72 %) · ssm · TCGA-SKCM · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | gdc | graph → |
| ← altered in cohorts of | PCDH15 339 / 470 cases (72 %) · ssm · TCGA-SKCM · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | gdc | graph → |
| ← altered in cohorts of | BNC2 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ELAVL2 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOCAD 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA21 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA6 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SH3GL2 337 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA10 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA13 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNB1 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNW1 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CER1 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA1 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA17 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA2 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA5 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL9 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MPDZ 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAXO1 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTLN 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HACD4 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA8 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TYRP1 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TACC2 333 / 470 cases (71 %) · ssm · TCGA-SKCM · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC171 331 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOCK8 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MLLT3 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC24A2 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TEK 330 / 470 cases (70 %) · ssm · TCGA-SKCM · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TTC39B 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HAUS6 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NFIB 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSIP1 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZDHHC21 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACER2 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRT3 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LURAP1L 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLIN2 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPS6 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMARCA2 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNAPC3 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND4C 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLIS3 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INSL6 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRAGA 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRT1 325 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IZUMO3 325 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | JAK2 325 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLDC 324 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KDM4C 324 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RCL1 324 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INSL4 323 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LINGO2 323 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CD274 322 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIAA2026 322 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SORCS3 322 / 470 cases (69 %) · ssm · TCGA-SKCM · largest of 4 cohorts | — | — | Cutaneous Melanoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | TPD52L3 322 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRT2 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERMP1 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL33 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNV2 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLGRKT 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RLN1 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMAC1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAH8 320 / 470 cases (68 %) · ssm · TCGA-SKCM · largest of 10 cohorts | — | — | Cutaneous Melanoma | 10 | Observed | gdc | graph → |
| ← altered in cohorts of | KANK1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDCD1LG2 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RANBP6 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RFX3 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIC1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RLN2 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC1A1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TUSC1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VLDLR 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C19 319 / 470 cases (68 %) · ssm · TCGA-SKCM · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | IFT74 319 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC19 319 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCDHAC2 184 / 346 cases (53 %) · ssm · skcm_tcga_pub_2015 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRB2 38 / 78 cases (49 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDHGC5 164 / 346 cases (47 %) · ssm · skcm_tcga_pub_2015 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRAF 301 / 696 cases (43 %) · ssm · mel_mskimpact_2020 · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CRIPAK 31 / 78 cases (40 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRG4 31 / 78 cases (40 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 182 / 469 cases (39 %) · ssm · skcm_tcga_gdc · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TCHH 29 / 78 cases (37 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIOBP 29 / 78 cases (37 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRT 254 / 696 cases (36 %) · ssm · mel_mskimpact_2020 · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 166 / 469 cases (35 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 156 / 469 cases (33 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 156 / 469 cases (33 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 151 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RP1 151 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 151 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HYDIN 149 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 148 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2A 217 / 696 cases (31 %) · ssm · mel_mskimpact_2020 · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 145 / 469 cases (31 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DSCAM 145 / 469 cases (31 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 143 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 141 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 141 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NRAS 207 / 696 cases (30 %) · ssm · mel_mskimpact_2020 · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 139 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | THSD7B 139 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 138 / 469 cases (29 %) · ssm · skcm_tcga_gdc · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 138 / 469 cases (29 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 137 / 469 cases (29 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRD 199 / 696 cases (29 %) · ssm · mel_mskimpact_2020 · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NF1 194 / 696 cases (28 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROS1 194 / 696 cases (28 %) · ssm · mel_mskimpact_2020 · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH3 130 / 469 cases (28 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MXRA5 129 / 469 cases (28 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPHKAP 128 / 469 cases (27 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAK5 189 / 696 cases (27 %) · ssm · mel_mskimpact_2020 · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBPF10 21 / 78 cases (27 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 183 / 696 cases (26 %) · ssm · mel_mskimpact_2020 · largest of 4 cohorts | — | — | Cutaneous Melanoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 122 / 469 cases (26 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RPTN 20 / 78 cases (26 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCAF11 20 / 78 cases (26 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF318 20 / 78 cases (26 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF845 20 / 78 cases (26 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF93 20 / 78 cases (26 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MACF1 110 / 440 cases (25 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM135B 116 / 469 cases (25 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL4A4 115 / 469 cases (25 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN11A 115 / 469 cases (25 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH2 113 / 469 cases (24 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 113 / 469 cases (24 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASXL3 112 / 469 cases (24 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MROH2B 112 / 469 cases (24 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 165 / 696 cases (24 %) · ssm · mel_mskimpact_2020 · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAPPA2 111 / 469 cases (24 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN10A 111 / 469 cases (24 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRA 81 / 346 cases (23 %) · ssm · skcm_tcga_pub_2015 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 109 / 469 cases (23 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB4 161 / 696 cases (23 %) · ssm · mel_mskimpact_2020 · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERICH3 108 / 469 cases (23 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 108 / 469 cases (23 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH1 107 / 469 cases (23 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 107 / 469 cases (23 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCC 106 / 469 cases (23 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 106 / 469 cases (23 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO15A 99 / 440 cases (23 %) · ssm · skcm_tcga_pan_can_atlas_2018 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYT10 27 / 121 cases (22 %) · ssm · skcm_broad | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BLTP1 98 / 440 cases (22 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RGPD4 98 / 440 cases (22 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2B 97 / 437 cases (22 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG2 104 / 469 cases (22 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 104 / 469 cases (22 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP63 153 / 696 cases (22 %) · ssm · mel_mskimpact_2020 · largest of 4 cohorts | — | — | Cutaneous Melanoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH10 103 / 469 cases (22 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NPAP1 103 / 469 cases (22 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 101 / 469 cases (22 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NCKAP5 26 / 121 cases (21 %) · ssm · skcm_broad | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FRG1BP 79 / 368 cases (21 %) · ssm · skcm_tcga · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3C2G 149 / 696 cases (21 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CD163 100 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA7 140 / 658 cases (21 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 93 / 440 cases (21 %) · ssm · skcm_tcga_pan_can_atlas_2018 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1E 99 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH4 99 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 99 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SI 99 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRANK1 99 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1 92 / 440 cases (21 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PREX2 98 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTNAP2 97 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TLL1 97 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 4 cohorts | — | — | Cutaneous Melanoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK3 91 / 440 cases (21 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BCLAF1 25 / 121 cases (21 %) · ssm · skcm_broad | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN3A 25 / 121 cases (21 %) · ssm · skcm_broad | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYSF 90 / 440 cases (20 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKD1L1 90 / 440 cases (20 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRG4 95 / 469 cases (20 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CMYA5 95 / 469 cases (20 %) · ssm · skcm_tcga_gdc · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAGEC1 95 / 469 cases (20 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCB4 95 / 469 cases (20 %) · ssm · skcm_tcga_gdc · largest of 5 cohorts | — | — | Cutaneous Melanoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL12A1 89 / 440 cases (20 %) · ssm · skcm_tcga_pan_can_atlas_2018 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1 89 / 440 cases (20 %) · ssm · skcm_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDKN2A 140 / 696 cases (20 %) · ssm · mel_mskimpact_2020 · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |